Aurora Cannabis Inc. (TSX: ACB) (OTCQX: ACBFF) announced today that it has received all the required permits to ship dried cannabis flower from Canada to Germany.
Cannabis News
Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals
Emerald Health Therapeutics Inc. (EHT) (TSXV:EMH) (OCTQX:EMHTF) today announced that its wholly owned subsidiary, Emerald Health Botanicals Inc., has completed a purchase of dried cannabis from Supreme Pharmaceuticals Inc.’s (TSXV:FIRE) subsidiary, 7ACRES.
The Green Organic Dutchman Holdings Ltd. Announces Financing Syndicate for $20 Million Offering
he Green Organic Dutchman Holdings Ltd. announces the syndicate for the offering of 4,242,500 Units of the Company at a price of C$1.65 per Unit for aggregate gross proceeds of C$7,000,125.
Copy of ABcann Global Receives $11.9 Million from Exercise of Warrants
ABcann Global receives $11.9 Million from the exercise of outstanding warrants.
ABcann Global Receives $11.9 Million from Exercise of Warrants
ABcann Global receives $11.9 Million from the exercise of outstanding warrants.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Nets Total Proceeds of $11.9 Million from Exercise of Warrants
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has received total proceeds of nearly $11.9 million from the exercise of an aggregate of 19,185,965 warrants since the closing of its acquisition of ABcann Medicinals Inc. on April 28, 2017.
The Bio Pharma Project Generator
StockHouse did an in-depth look at InMed Pharmaceuticals (CSE: IN, OTCQB: IMLFF) about their model, technology and the "Big Picture"
Interview with ABcann Global (OTC: ABCCF TSX.V: ABCN) CEO Aaron Keay
The Seed Investor sits down with ABcann CEO Aaron Keay to discuss ABcann and what it takes to be the strongest grower in the Marijuana sector.
Recent Competitor Recalls Illustrate Importance of ABcann Global’s (TSX.V: ABCN) (OTCQB: ABCCF) Innovative, Pesticide-Free Cannabis Growth Practices
Ken Clement said in an update published on the ABcann website. “Providing a high quality, standardized pesticide-free product to our patients remains our number one priority as we initiate our largest expansion plans to date.”
Canopy Growth and New Brunswick Sign Historic Supply MOU
Canopy Growth Corporation (TSX: WEED) and the Province of New Brunswick today announced a significant milestone in the history of Canadian cannabis, entering into an agreement to guarantee a reliable and high-quality supply of cannabis products into New Brunswick's retail stores.
University of British Columbia to Conduct Clinical Study of Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Game-Changing Oral CBD Product
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral CBD intake, having engineered the product to enhance absorption through the intestinal tract without active compounds being destroyed by stomach acid or broken down by the liver, and this revolutionary product also masks the unpleasant flavor of cannabis compounds.
INMED PHARMACEUTIC COM NPV (CSE: IN OTCBB: IMLFF) Closes In Green
InMed Pharmaceuticals (CSE: IN OTCBB: IMLFF) is picking up steam, with another recent article in MMJReporter.com
Cronos (TSX.V MJN) Announces Private Placement of Common Shares
Cronos Group expects to issue up to 4,444,444 common shares at $2.25
Eaze Continues Advancing Cannabis Industry with an Additional $27M Raised
Eaze, the leading cannabis technology company, announced today an additional $27 million in Series B financing, led by Bailey Capital with participation from DCM Ventures, Kaya Ventures and FJ Labs.
Canopy Growth Completes Sale of Non-Core Subsidiary for $7.0 Million and Enters Three Year Product Supply Agreement
Canopy Growth Corporation (TSX:WEED) has completed an agreement with Cannabis Care Canada Inc. to sell its wholly-owned subsidiary Mettrum (Bennett North) Ltd. , which is licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations to produce and sell dried cannabis and cannabis oil.